The separation of mental and physical health into distinct clinical domains is an administrative convenience, not a biological reality. The neurological, endocrine, and immune systems are in constant bidirectional communication. Psychological states modify physiology in specific, measurable ways, and psychological interventions can produce improvements in physical health outcomes that are comparable in magnitude to pharmacological interventions for some conditions. The evidence base for this is now extensive.
Chronic Pain and Psychological Intervention
A 2021 meta-analysis of psychological therapies for chronic lower back pain found that cognitive behavioural therapy and acceptance and commitment therapy both produced clinically significant and sustained reductions in pain intensity and disability, comparable in effect size to the best available physical therapies. The NICE guidance on chronic primary pain now recommends psychological therapy as a first-line treatment, ahead of pharmacological options, for adults where pain has become primarily centrally mediated.
Cardiovascular and Immune Outcomes
Psychological interventions have demonstrated measurable effects on cardiovascular risk markers including blood pressure, heart rate variability, and inflammatory markers. Mindfulness-based stress reduction consistently reduces cortisol, IL-6, and CRP across randomised trials. Among post-myocardial infarction patients, psychological support interventions reduce recurrent cardiac events by 20 to 30 percent in several trials, an effect attributable to improved autonomic regulation and reduced inflammatory burden.
Sources
- Veehof, M.M., et al. (2016). Acceptance and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review. Cognitive Behaviour Therapy, 45(1), 5-31.
- NICE Guideline NG193. (2021). Chronic pain (primary and secondary) in over 16s. National Institute for Health and Care Excellence.
- Blumenthal, J.A., et al. (2005). Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease. JAMA, 293(13), 1626-1634.